FDA Inspection
S&B Pharma LLC DBA Norac PharmaS&B Pharma LLC DBA Norac Pharma – FDA Inspection, May 22, 2015
Record Details
This FDA Inspection record concerns S&B Pharma LLC DBA Norac Pharma, with an inspection on May 22, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 22, 2015
- Product Type
- Drugs
View Company Profile
ID · 695a4e7b-17a3-4507-8919-e481d312235b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 928478
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of S&B Pharma LLC DBA Norac Pharma
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | Not classified | Los Angeles District Office | |
| August 10, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 10, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 2, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 3, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for S&B Pharma LLC DBA Norac Pharma
- FDA Inspection 1287536 - 2025-09-19
- FDA Inspection 1067410 - 2018-08-10
- FDA Inspection 827719 - 2013-04-10
- FDA Inspection 759410 - 2011-12-02
- FDA Inspection 575623 - 2009-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.